Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,854
datasets available to search
ShareScore release 0.9.0
Dataset results
2,854 results for “Hepatocellular carcinoma”
Doxorubicin By Infusion or Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)
ClinicalTrials.gov study NCT00079027. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combined HAIC, Lenvatinib and Cadonilimab As Conversion Therapy for Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT06187961. IPD Sharing: NO. Countries: 1. Publications: 0.
Liver Resection for Patients With Hepatocellular Carcinoma and Impaired Liver Function
ClinicalTrials.gov study NCT06245785. IPD Sharing: NO. Countries: 1. Publications: 0.
PET / MR With PSMA for Diagnosis and Staging of Hepatocellular Carcinoma
ClinicalTrials.gov study NCT05580835. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Curative Therapy After Atezolizumab and Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT07091942. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nivolumab and Bevacizumab in Patients With Advanced and or Metastatic Hepatocellular Carcinoma
ClinicalTrials.gov study NCT03382886. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
ClinicalTrials.gov study NCT06915753. IPD Sharing: UNDECIDED. Countries: 4. Publications: 0.
Autologous Neoantigen-Specific T-Cell Therapy for Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT07123545. IPD Sharing: NO. Countries: 1. Publications: 0.
Toripalimab or Placebo as Adjuvant Therapy in Hepatocellular Carcinoma After Radical Resection
ClinicalTrials.gov study NCT03859128. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Epidemiologic Study of Hepatocellular Carcinoma in the US
ClinicalTrials.gov study NCT02358070. IPD Sharing: Not stated. Countries: 1. Publications: 0.
IL1RAP-targeting Chimeric Antigen Receptor T Cells in the Treatment of Relapsed/Refractory Hepatocellular Carcinoma
ClinicalTrials.gov study NCT06757881. IPD Sharing: NO. Countries: 1. Publications: 0.
A National Phase II Study of Proton Therapy in Hepatocellular Carcinoma
ClinicalTrials.gov study NCT05203120. IPD Sharing: NO. Countries: 1. Publications: 0.
Dose Escalation Study Using Proton Beam Radiotherapy for Hepatocellular Carcinoma
ClinicalTrials.gov study NCT00662246. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Icaritin Soft Capsules+TACE+Immunotherapy+Targeted Therapy Versus TACE+Immunotherapy+Targeted Therapy for Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT06896396. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib as Second-line or Later Therapy in Patients With Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT05675462. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of BBI503 in Advanced Solid Tumors, or BBI503/ Sorafenib in Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT02354898. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Sorafenib Therapy Prior to Laser Ablation for Hepatocellular Carcinoma
ClinicalTrials.gov study NCT01507064. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Galunisertib (LY2157299) Plus Stereotactic Body Radiotherapy (SBRT) in Advanced Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT02906397. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Locoregional Therapy Combined With Bevacizumab and PD1/L1 Inhibitor in Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT06323382. IPD Sharing: NO. Countries: 1. Publications: 0.
Correlation Between Sorafenib Plasma Concentrations, Toxicity and Disease Control Rate in Patients Treated by Sorafenib for Hepatocellular Carcinoma
ClinicalTrials.gov study NCT02834546. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.